NEW YORK and LONDON, May 26, 2016
Akari Therapeutics (NASDAQ: AKTX), an emerging growth, clinical-stage biopharmaceutical company, today announced that Gur Roshwalb, MD, Chief Executive Officer, will present and participate in a question-and-answer session at the Jefferies 2016 Healthcare Conference on Thursday, June 9, 2016 at 10:00 a.m. ET.
